AtaiBeckley (ATAI) Operating Expenses (2020 - 2026)
AtaiBeckley (ATAI) posted Operating Expenses of $29.2 million for Q3 2025, up 12.28% sequentially from $26.0 million in Q2 2025, and up 28.9% YoY from $22.6 million in Q3 2024.
AtaiBeckley (ATAI) Operating Expenses (2020 - 2026) Analysis & Trends
AtaiBeckley's Operating Expenses history runs 2 years deep, the most recent figure standing at $31.9 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 45.29% year-over-year to $31.9 million; the TTM figure through Mar 2026 stood at $53.8 million (changed N/A YoY), while the FY2025 annual figure was $648.2 million, up 529.28% from the prior year.
- Operating Expenses climbed to $29.2 million in Q3 2025 per ATAI's latest filing, from $26.0 million in the prior quarter.
- The five-year high for Operating Expenses was $31.9 million in Q1 2026, with the low at $21.9 million in Q1 2025.
- A 5-year average of $32.0 million and a median of $32.0 million in 2023 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 952.69% in 2021, down 47.95% in 2021.
- Over 5 years, Operating Expenses stood at $45.4 million in 2021, then fell by 17.18% to $37.6 million in 2022, then retreated by 10.7% to $33.6 million in 2023, then dropped by 9.88% to $30.3 million in 2024, then slipped by 3.55% to $29.2 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $29.2 million, $26.0 million, and $21.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | AtaiBeckley | 2.69 Bn | 2.69 Bn | - | 29.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.85 Mn |
| Mar 31, 2026 | 31.86 Mn |
| Sep 30, 2025 | 29.19 Mn |
| Jun 30, 2025 | 25.99 Mn |
| Mar 31, 2025 | 21.93 Mn |
| Mar 31, 2025 | 21.93 Mn |
| Dec 31, 2024 | 30.26 Mn |
| Sep 30, 2024 | 22.64 Mn |
| Jun 30, 2024 | 26.00 Mn |
| Mar 31, 2024 | 24.09 Mn |
| Dec 31, 2023 | 33.58 Mn |
| Sep 30, 2023 | 26.92 Mn |
| Jun 30, 2023 | 32.03 Mn |
| Mar 31, 2023 | 33.25 Mn |
| Dec 31, 2022 | 37.60 Mn |
| Sep 30, 2022 | 38.45 Mn |
| Jun 30, 2022 | 35.53 Mn |
| Mar 31, 2022 | 33.44 Mn |
| Dec 31, 2021 | 45.41 Mn |
| Sep 30, 2021 | 33.63 Mn |